You already know someone who suffered for no good reason.
We built Vana because we couldn't keep pretending that was normal. We're working toward free, universal healthcare — and it starts with people like you deciding to stop looking away.
Takes 30 seconds. Costs nothing. Changes what we're able to build.
Somewhere, right now, someone you love is being failed.
Not by doctors who don't care. By a system that was never built to care back.
A mother rationing insulin. A father who waited too long because the visit cost more than he had. A friend who stopped mentioning the pain because nobody seemed to be doing anything about it anyway.
Most of us learned to look past this. Not because we're cruel — because looking at it straight on, every day, would be unbearable. So we go numb. We scroll past. We tell ourselves someone else is handling it.
No one is handling it. That's the part we stopped being able to ignore.
Simple enough to explain in three sentences. Because it should be.
You don't have to understand biotech. You just have to be willing to show up for yourself, a little, every day. We'll handle the rest — starting with Vee, the daily companion that makes it easy.
Check in with Vee
A friendly daily check-in on symptoms, meds, and labs — thirty seconds, not a survey. Vee remembers, so you don't have to repeat yourself.
Vee builds your record
Every check-in becomes part of one connected, plain-language record — replacing the dozen disconnected portals you're used to.
You decide what's shared
Nothing leaves your record without your say-so. Consent is granted per data type — labs, meds, symptoms — and you can revoke it anytime.
Your data can help close the gap for others
With your consent, it can support research and drug development that's never had real access to people like you. Free to you — funded by the partners who license it, not by you.
Your digital twin, right on your home screen
The idea: your avatar's condition mirrors yours. Skip a check-in or run a fever, and Vee looks a little under the weather too — so caring for it means caring for the record that helps you and the research that could help someone else.
Synced with your wearables. Glucose monitors, smartwatches, rings — the numbers you're already generating, pulled into one simple view instead of five different apps.
A reason to come back daily. Streaks, points, and a friendly nudge to take your meds — the same habit-forming mechanics that make Duolingo hard to quit, aimed at something that actually matters.
Someone to talk to. Vee isn't just a data form — it's a check-in on how you're actually doing, with support for the harder days too.
Conceptual mockup — current design in progress, not yet available.
You're the reason any of this works.
Every treatment that's ever reached a pharmacy shelf started with a patient who trusted someone else with their information — and usually never heard about it again. We think that's backwards. Here's what this actually costs, from three sides of the same problem.
Every new specialist means repeating your story from scratch — symptoms, timelines, medications, all of it, again. Vana Healthcare means you tell it once.
You're the one holding the binder, the portal logins, the timeline no single doctor has time to read in full. Vana Healthcare keeps it in one place — built for you, not just about the person you're caring for.
Researchers studying rare and complex conditions have always needed real-world, longitudinal patient data. It's existed the whole time — just never connected, never consented at the source, never actually accessible. Vana Healthcare is how that changes.
Built first for multiple myeloma and its precursor conditions — the wedge, not the ceiling
Right now, 19 active post-marketing studies are tracking the newest wave of multiple myeloma treatments — bispecific antibodies and CAR-T therapies approved between 2021 and 2024, sponsored directly by companies like Regeneron and Johnson & Johnson. Vana Healthcare starts earlier in that same journey: with the years of watch-and-wait monitoring patients live through with MGUS and smoldering myeloma, long before — and long after — a diagnosis of active disease.
Source: ClinicalTrials.gov, live trial search, August 2026.
One condition first. Not the only one.
We're starting narrow on purpose — proving the model before widening it.
Multiple myeloma & its precursor conditions
Consented, longitudinal data licensed to pharma partners already running post-marketing studies. We plug into the drug-discovery and data infrastructure that already exists — we're not building a discovery engine from day one.
Cardiometabolic disease (obesity, type 2 diabetes)
A much larger population with daily-tracking habits already in place — glucose logs, meds, weight. As the data layer matures here, so does the case for building our own discovery and benchmarking capability, rather than only plugging into others'.
Mental health & psychedelic-assisted therapy
An area with real momentum and a real data gap — 144 active or upcoming psilocybin and MDMA-assisted therapy trials right now, most still small. By this phase, our own discovery engine runs benchmarked alongside partners', not instead of them.
Ownership isn't a slogan here — it's how the product works
Every design decision starts from one rule: it's your data, so you decide.
You approve every share, every time — not a blanket privacy setting, an actual decision you make.
Encrypted, and never sold. Vana doesn't make money by selling your data to advertisers or brokers.
Leave anytime, no penalty. Delete your data or close your account whenever you want — no dark patterns.
Free to you, because pharma funds it. Vana Healthcare doesn't charge patients. Research and pharma partners pay for consented, de-identified insights — only with your explicit permission.
"I didn't start this because I had a clever business idea. I started it because I got tired of watching people I love get failed by a system that was never built for them, and feeling like there was nothing I could personally do about it.
There is something we can do. Not overnight. Not alone. But if enough of us decide our health information is worth something — worth using on our own behalf, for once — we can build the kind of leverage that's never existed before: real people, real data, real consent, aimed at the actual problem instead of around it.
I don't know exactly how long this takes. I know it doesn't happen if we wait for someone else to start."
Why give your data
Vana Healthcare might not undo years of searching for the right diagnosis. But the data you choose to share today could be the reason someone else's search takes months, not years. Reducing suffering in healthcare, one consented data point at a time — that's the whole point.
The post-marketing data you're already funding — just not from a source like this
Vana Healthcare starts in multiple myeloma and its precursor conditions, where newly approved bispecific antibodies and CAR-T therapies carry active, sponsor-funded post-marketing commitments — 19 Phase 4 studies are running right now, funded by companies like Regeneron and Johnson & Johnson. We're building to deliver structured, consented, longitudinal patient data spanning years before diagnosis through treatment and beyond — not a claims extract assembled after the fact. Pre-launch today; that's the product we're building toward.
Partner / institution logos go here once confirmed
Common questions
Is my data ever sold? +
No. Never. Vana doesn't make money by selling personal data to advertisers, employers, or insurers. (Full data policy link — placeholder, add before launch.)
Do I have to share everything? +
No — you choose exactly what's shared and with whom, section by section. You can share your medication history with a researcher and nothing else, for example.
Is Vana a hospital or insurance company? +
No. Vana doesn't provide medical care or coverage. Think of it as your own health data home base that sits alongside your existing care team.
What if I have a common condition, not a rare one? +
Vana works for anyone who wants to own and understand their health data. Rare and complex conditions are where we started — not where we stop.
How is my data kept secure? +
We're building this in from day one, not bolting it on later: HIPAA-aligned infrastructure, encryption at rest and in transit, and a signed data agreement with every partner before any data moves. A SOC 2 audit is part of our early roadmap. We're pre-launch — this is the standard we're building to, and we'd rather say that plainly than claim a certification we don't have yet.